Benzinga's Volume Movers

Lexicon Pharmaceuticals, Inc. LXRX surged 21.5 percent to $18.61. The volume of Lexicon Pharmaceuticals shares traded was 3171 percent higher than normal. Lexicon reported first successful Phase 3 trial of an oral anti-diabetic for Type 1 diabetes.
CoLucid Pharmaceuticals Inc CLCD shares moved up 6.9 percent to $22.07. The volume of CoLucid Pharmaceuticals traded was 2001 percent higher than normal. CoLucid Pharmaceuticals reported a proposed public offering of common stock.
Finisar Corporation FNSR shares rose 12.6 percent to $26.15. The volume of Finisar shares traded was 1541 percent higher than normal. Finisar reported upbeat results for its first quarter and issued a strong forecast for the current quarter.
PDC Energy Inc PDCE shares rose 3.1 percent to $66.81. The volume of PDC Energy shares traded was 848 percent higher than normal. PDC Energy disclosed the pricing of public offerings of common stock and convertible senior notes.